The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity

女性特有的因子VGLL3驱动皮肤和系统性自身免疫

阅读:1
作者:Allison C Billi ,Mehrnaz Gharaee-Kermani ,Joseph Fullmer ,Lam C Tsoi ,Brett D Hill ,Dennis Gruszka ,Jessica Ludwig ,Xianying Xing ,Shannon Estadt ,Sonya J Wolf ,Syed Monem Rizvi ,Celine C Berthier ,Jeffrey B Hodgin ,Maria A Beamer ,Mrinal K Sarkar ,Yun Liang ,Ranjitha Uppala ,Shuai Shao ,Chang Zeng ,Paul W Harms ,Monique E Verhaegen ,John J Voorhees ,Fei Wen ,Nicole L Ward ,Andrzej A Dlugosz ,J Michelle Kahlenberg ,Johann E Gudjonsson

Abstract

Autoimmune disease is 4 times more common in women than men. This bias is largely unexplained. Female skin is "autoimmunity prone," showing upregulation of many proinflammatory genes, even in healthy women. We previously identified VGLL3 as a putative transcription cofactor enriched in female skin. Here, we demonstrate that skin-directed overexpression of murine VGLL3 causes a severe lupus-like rash and systemic autoimmune disease that involves B cell expansion, autoantibody production, immune complex deposition, and end-organ damage. Excess epidermal VGLL3 drives a proinflammatory gene expression program that overlaps with both female skin and cutaneous lupus. This includes increased B cell-activating factor (BAFF), the only current biologic target in systemic lupus erythematosus (SLE); IFN-κ, a key inflammatory mediator in cutaneous lupus; and CXCL13, a biomarker of early-onset SLE and renal involvement. Our results demonstrate that skin-targeted overexpression of the female-biased factor VGLL3 is sufficient to drive cutaneous and systemic autoimmune disease that is strikingly similar to SLE. This work strongly implicates VGLL3 as a pivotal orchestrator of sex-biased autoimmunity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。